Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Front Cardiovasc Med ; 10: 1119699, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37077747

RESUMO

Objective: Risk stratification of patients with congestive heart failure (HF) is vital in clinical practice. The aim of this study was to construct a machine learning model to predict the in-hospital all-cause mortality for intensive care unit (ICU) patients with HF. Methods: eXtreme Gradient Boosting algorithm (XGBoost) was used to construct a new prediction model (XGBoost model) from the Medical Information Mart for Intensive Care IV database (MIMIC-IV) (training set). The eICU Collaborative Research Database dataset (eICU-CRD) was used for the external validation (test set). The XGBoost model performance was compared with a logistic regression model and an existing model (Get with the guideline-Heart Failure model) for mortality in the test set. Area under the receiver operating characteristic cure and Brier score were employed to evaluate the discrimination and the calibration of the three models. The SHapley Additive exPlanations (SHAP) value was applied to explain XGBoost model and calculate the importance of its features. Results: The total of 11,156 and 9,837 patients with congestive HF from the training set and test set, respectively, were included in the study. In-hospital all-cause mortality occurred in 13.3% (1,484/11,156) and 13.4% (1,319/9,837) of patients, respectively. In the training set, of 17 features with the highest predictive value were selected into the models with LASSO regression. Acute Physiology Score III (APS III), age and Sequential Organ Failure Assessment (SOFA) were strongest predictors in SHAP. In the external validation, the XGBoost model performance was superior to that of conventional risk predictive methods, with an area under the curve of 0.771 (95% confidence interval, 0.757-0.784) and a Brier score of 0.100. In the evaluation of clinical effectiveness, the machine learning model brought a positive net benefit in the threshold probability of 0%-90%, prompting evident competitiveness compare to the other two models. This model has been translated into an online calculator which is accessible freely to the public (https://nkuwangkai-app-for-mortality-prediction-app-a8mhkf.streamlit.app). Conclusion: This study developed a valuable machine learning risk stratification tool to accurately assess and stratify the risk of in-hospital all-cause mortality in ICU patients with congestive HF. This model was translated into a web-based calculator which access freely.

2.
Front Digit Health ; 3: 676824, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34713147

RESUMO

Self-awareness is an essential concept in physiology and psychology. Accurate overall self-awareness benefits the development and well being of an individual. The previous research studies on self-awareness mainly collect and analyze data in the laboratory environment through questionnaires, user study, or field research study. However, these methods are usually not real-time and unavailable for daily life applications. Therefore, we propose a new direction of utilizing lifelog for self-awareness. Lifelog records about daily activities are used for analysis, prediction, and intervention on individual physical and psychological status, which can be automatically processed in real-time. With the help of lifelog, ordinary people are able to understand their condition more precisely, get effective personal advice about health, and even discover physical and mental abnormalities at an early stage. As the first step on using lifelog for self-awareness, we learn from the traditional machine learning problems, and summarize a schema on data collection, feature extraction, label tagging, and model learning in the lifelog scenario. The schema provides a flexible and privacy-protected method for lifelog applications. Following the schema, four topics were conducted: sleep quality prediction, personality detection, mood detection and prediction, and depression detection. Experiments on real datasets show encouraging results on these topics, revealing the significant relation between daily activity records and physical and psychological self-awareness. In the end, we discuss the experiment results and limitations in detail and propose an application, Lifelog Recorder, for multi-dimensional self-awareness lifelog data collection.

3.
Front Cardiovasc Med ; 8: 620857, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33889598

RESUMO

Background: It is unknown to what extent the clinical benefits of PCI outweigh the risks and costs in patients with vs. without cancer and within each cancer type. We performed the first known nationally representative propensity score analysis of PCI mortality and cost among all eligible adult inpatients by cancer and its types. Methods: This multicenter case-control study used machine learning-augmented propensity score-adjusted multivariable regression to assess the above outcomes and disparities using the 2016 nationally representative National Inpatient Sample. Results: Of the 30,195,722 hospitalized patients, 15.43% had a malignancy, 3.84% underwent an inpatient PCI (of whom 11.07% had cancer and 0.07% had metastases), and 2.19% died inpatient. In fully adjusted analyses, PCI vs. medical management significantly reduced mortality for patients overall (among all adult inpatients regardless of cancer status) and specifically for cancer patients (OR 0.82, 95% CI 0.75-0.89; p < 0.001), mainly driven by active vs. prior malignancy, head and neck and hematological malignancies. PCI also significantly reduced cancer patients' total hospitalization costs (beta USD$ -8,668.94, 95% CI -9,553.59 to -7,784.28; p < 0.001) independent of length of stay. There were no significant income or disparities among PCI subjects. Conclusions: Our study suggests among all eligible adult inpatients, PCI does not increase mortality or cost for cancer patients, while there may be particular benefit by cancer type. The presence or history of cancer should not preclude these patients from indicated cardiovascular care.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA